| Year |
Citation |
Score |
| 2023 |
O'Toole R, Martinez KA, Rothberg MB, Diiorio G, Stenehjem EA, Ward KE, LaPlante KL. Antibiotics on Demand: Advances in Asynchronous Telemedicine Call for Increased Antibiotic Surveillance. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37642218 DOI: 10.1093/cid/ciad472 |
0.308 |
|
| 2023 |
Liao JX, Appaneal HJ, Menon A, Lopes V, LaPlante KL, Caffrey AR. Decreasing Antibiotic Resistance Trends Nationally in Gram-Negative Bacteria Across United States Veterans Affairs Medical Centers, 2011-2020. Infectious Diseases and Therapy. PMID 37326931 DOI: 10.1007/s40121-023-00827-9 |
0.355 |
|
| 2022 |
Appaneal HJ, Lopes VV, LaPlante KL, Caffrey AR. Trends in antibiotic resistance rates in the United States Veterans Affairs Health System. Journal of Medical Microbiology. 71. PMID 36306237 DOI: 10.1099/jmm.0.001594 |
0.306 |
|
| 2022 |
Appaneal HJ, Caffrey AR, Lopes V, Piehl EC, Puzniak LA, LaPlante KL. Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa. Microbiology Spectrum. e0233622. PMID 36005836 DOI: 10.1128/spectrum.02336-22 |
0.35 |
|
| 2022 |
Amin AN, Dellinger EP, Harnett G, Kraft BD, LaPlante KL, LoVecchio F, McKinnell JA, Tillotson G, Valentine S. It's about the patients: Practical antibiotic stewardship in outpatient settings in the United States. Frontiers in Medicine. 9: 901980. PMID 35966853 DOI: 10.3389/fmed.2022.901980 |
0.322 |
|
| 2022 |
LaPlante KL, Dhand A, Wright K, Lauterio M. Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance. Annals of Medicine. 54: 1686-1700. PMID 35723082 DOI: 10.1080/07853890.2022.2085881 |
0.39 |
|
| 2021 |
Appaneal HJ, O'Neill E, Lopes VV, LaPlante KL, Caffrey AR. National trends in hospital, long-term care and outpatient resistance rates. Journal of Medical Microbiology. 70. PMID 34919041 DOI: 10.1099/jmm.0.001473 |
0.347 |
|
| 2021 |
Deering RW, Whalen KE, Alvarez I, Daffinee K, Beganovic M, LaPlante KL, Kishore S, Zhao S, Cezairliyan B, Yu S, Rosario M, Mincer TJ, Rowley DC. Identification of a bacteria-produced benzisoxazole with antibiotic activity against multi-drug resistant Acinetobacter baumannii. The Journal of Antibiotics. PMID 33580212 DOI: 10.1038/s41429-021-00412-7 |
0.632 |
|
| 2020 |
Piehl EC, Daffinee KE, LaPlante K. 1323. Substantial Doses of Daptomycin and Rifampin Eradicate S. epidermidis Biofilm in an In Vitro Pharmacodynamic (IVPD) Model Open Forum Infectious Diseases. 7: S672-S673. DOI: 10.1093/ofid/ofaa439.1505 |
0.304 |
|
| 2019 |
Gil D, Daffinee K, Friedman R, Bhushan B, Muratoglu OK, LaPlante K, Oral E. Synergistic antibacterial effects of analgesics and antibiotics against Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease. 114967. PMID 32057521 DOI: 10.1016/J.Diagmicrobio.2019.114967 |
0.49 |
|
| 2019 |
Cusumano JA, Caffrey AR, Daffinee KE, Luther MK, Lopes V, LaPlante KL. Weak biofilm formation among carbapenem-resistant Klebsiella pneumoniae. Diagnostic Microbiology and Infectious Disease. 114877. PMID 31484626 DOI: 10.1016/j.diagmicrobio.2019.114877 |
0.388 |
|
| 2019 |
Beganovic M, Luther MK, Daffinee KE, LaPlante KL. Biofilm prevention concentrations (BPC) of minocycline compared to polymyxin B, meropenem, and amikacin against Acinetobacter baumannii. Diagnostic Microbiology and Infectious Disease. PMID 30827805 DOI: 10.1016/j.diagmicrobio.2019.01.016 |
0.35 |
|
| 2019 |
Bodo EC, Daffinee KE, LaPlante K. 620. Sub-MIC Concentrations of Levofloxacin and Delafloxacin Enhance Staphylococcus aureus Biofilm Formation: Significance of Maximizing Exposure Open Forum Infectious Diseases. 6: S288-S288. DOI: 10.1093/Ofid/Ofz360.688 |
0.466 |
|
| 2019 |
Bodo EC, Caffrey A, Lopes V, Cusumano JA, Puzniak LA, McCann E, LaPlante K. 2291. Evaluation of Multidrug-Resistant Pseudomonas aeruginosa Isolates in Patients Receiving Ceftolozane/tazobactam Open Forum Infectious Diseases. 6: S785-S785. DOI: 10.1093/Ofid/Ofz360.1969 |
0.422 |
|
| 2019 |
Appaneal H, Caffrey A, Hughes S, Lopes V, Jump RL, Dosa D, LaPlante K. 2049. Trends in Antibiotic Use and Antibiotic Resistance among Veterans Affairs Community Living Centers from 2011 to 2017 Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.1729 |
0.439 |
|
| 2018 |
LaPlante K, Cusumano J, Tillotson G. Colistin for the treatment of multidrug-resistant infections. The Lancet. Infectious Diseases. 18: 1174-1175. PMID 30507395 DOI: 10.1016/S1473-3099(18)30611-X |
0.392 |
|
| 2018 |
LaPlante K, Hutchison ML, St Amand AB. Re: Disparities Between Parental Expectations and Pediatric Antibiotic Prescribing. Pediatrics. PMID 29602901 DOI: 10.1542/Peds.2018-0065 |
0.346 |
|
| 2017 |
Appaneal HJ, Caffrey AR, Jiang L, Dosa D, Mermel LA, LaPlante KL. Antibiotic resistance rates for Pseudomonas aeruginosa clinical respiratory and bloodstream isolates among the Veterans Affairs Healthcare System from 2009 to 2013. Diagnostic Microbiology and Infectious Disease. PMID 29310949 DOI: 10.1016/j.diagmicrobio.2017.11.022 |
0.36 |
|
| 2017 |
LaPlante KL, Gill CM, Rowley D. Cranberry Capsules for Bacteriuria Plus Pyuria in Nursing Home Residents. Jama. 317: 1078. PMID 28291884 DOI: 10.1001/Jama.2017.0089 |
0.457 |
|
| 2017 |
Morrill HJ, Morton JB, Caffrey AR, Jiang L, Dosa D, Mermel LA, LaPlante KL. Antimicrobial resistance of Escherichia coli urinary isolates in the Veterans Affairs Healthcare System. Antimicrobial Agents and Chemotherapy. PMID 28193660 DOI: 10.1128/AAC.02236-16 |
0.361 |
|
| 2017 |
Beganovic M, Luther M, Daffinee K, LaPlante K. Impact of minocycline, polymyxin B, meropenem, and amikacin on growth-prevention of Acinetobacter baumannii with various biofilm-forming capabilities Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.657 |
0.326 |
|
| 2017 |
Caffrey A, Beganovic M, Lopes V, LaPlante K. Post-Discharge Antibiotic Therapy in Patients with Acute Bacterial Skin and Skin Structure Infections Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.118 |
0.33 |
|
| 2016 |
Luther MK, Rice LB, LaPlante KL. Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model. Antimicrobial Agents and Chemotherapy. 60: 3178-82. PMID 26926624 DOI: 10.1128/AAC.03126-15 |
0.307 |
|
| 2016 |
Luther MK, Mermel LA, LaPlante KL. Comparison of telavancin and vancomycin lock solutions in eradication of biofilm-producing staphylococci and enterococci from central venous catheters. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 73: 315-21. PMID 26896504 DOI: 10.2146/ajhp150029 |
0.318 |
|
| 2016 |
Morrill HJ, Caffrey AR, Jump RL, Dosa D, LaPlante KL. Antimicrobial Stewardship in Long-Term Care Facilities: A Call to Action. Journal of the American Medical Directors Association. 17: 183.e1-16. PMID 26778488 DOI: 10.1016/j.jamda.2015.11.013 |
0.331 |
|
| 2015 |
Sun J, Marais JP, Khoo C, LaPlante K, Vejborg RM, Givskov M, Tolker-Nielsen T, Seeram NP, Rowley DC. Cranberry (Vaccinium macrocarpon) oligosaccharides decrease biofilm formation by uropathogenic Escherichia coli. Journal of Functional Foods. 17: 235-242. PMID 26613004 DOI: 10.1016/J.Jff.2015.05.016 |
0.569 |
|
| 2015 |
Luther M, LaPlante KL. Observed antagonistic effect of linezolid on daptomycin or vancomycin activity against biofilm-forming methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model. Antimicrobial Agents and Chemotherapy. PMID 26369963 DOI: 10.1128/AAC.01604-15 |
0.346 |
|
| 2015 |
Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections. Open Forum Infectious Diseases. 2: ofv050. PMID 26125030 DOI: 10.1093/ofid/ofv050 |
0.302 |
|
| 2015 |
Gomes DM, Ward KE, LaPlante KL. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus. Pharmacotherapy. 35: 424-32. PMID 25884530 DOI: 10.1002/phar.1577 |
0.366 |
|
| 2015 |
Morrill HJ, LaPlante KL. Overconsumption of antibiotics. The Lancet. Infectious Diseases. 15: 377-8. PMID 25809891 DOI: 10.1016/S1473-3099(15)70083-6 |
0.397 |
|
| 2015 |
Tarquinio K, Travers C, LaPlante K. 430: Bacterial Isolate Comparison From Endotracheal Tubes And Tracheal Aspirates In Pediatric Patients Critical Care Medicine. 43: 109. DOI: 10.1097/01.Ccm.0000474258.33256.6E |
0.355 |
|
| 2015 |
Morrill H, Caffrey A, Noh E, Laplante K. Effect of Target Vancomycin Trough Concentrations of 15-20 mg/L on Clinical Outcomes in Obese Patients with Suspected Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1396 |
0.397 |
|
| 2014 |
Oh D, Sun J, Nasrolahi Shirazi A, LaPlante KL, Rowley DC, Parang K. Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens. Molecular Pharmaceutics. 11: 3528-36. PMID 25157458 DOI: 10.1021/Mp5003027 |
0.616 |
|
| 2014 |
Caffrey AR, Morrill HJ, Puzniak LA, LaPlante KL. Predictors of clinical success among a national Veterans Affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia. Clinical Therapeutics. 36: 552-9. PMID 24631473 DOI: 10.1016/j.clinthera.2014.02.013 |
0.341 |
|
| 2014 |
Caffrey AR, Morrill HJ, Puzniak LA, Laplante KL. Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia. Pharmacotherapy. 34: 473-80. PMID 24420846 DOI: 10.1002/phar.1390 |
0.375 |
|
| 2014 |
Tarquinio K, Confreda K, Shurko J, LaPlante K. Activities of tobramycin and polymyxin E against Pseudomonas aeruginosa biofilm-coated medical grade endotracheal tubes. Antimicrobial Agents and Chemotherapy. 58: 1723-9. PMID 24379207 DOI: 10.1128/AAC.01178-13 |
0.303 |
|
| 2014 |
Morrill H, Caffrey A, Gaitanis M, Laplante K. 224Impact of an Antimicrobial Stewardship Program (ASP) on antimicrobial use and clinical outcomes at a Veterans Affairs (VA) Teaching Hospital Open Forum Infectious Diseases. 1. DOI: 10.1093/Ofid/Ofu052.90 |
0.316 |
|
| 2014 |
Morrill H, Caffrey A, Noh E, Laplante K. 192Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia Open Forum Infectious Diseases. 1. DOI: 10.1093/Ofid/Ofu052.58 |
0.329 |
|
| 2012 |
Forschner-Dancause S, LaPlante K, Smith DC, Rowley DC. Going deep for drug discovery: an ocean to bedside approach to explore sub-seafloor microbes for the next generation of antibiotics. Medicine and Health, Rhode Island. 95: 292-3. PMID 23094427 |
0.537 |
|
| 2012 |
LaPlante KL, Sarkisian SA, Woodmansee S, Rowley DC, Seeram NP. Effects of cranberry extracts on growth and biofilm production of Escherichia coli and Staphylococcus species. Phytotherapy Research : Ptr. 26: 1371-4. PMID 22294419 DOI: 10.1002/Ptr.4592 |
0.628 |
|
| 2012 |
Sarkisian SA, Janssen MJ, Matta H, Henry GE, Laplante KL, Rowley DC. Inhibition of bacterial growth and biofilm production by constituents from Hypericum spp. Phytotherapy Research : Ptr. 26: 1012-6. PMID 22170780 DOI: 10.1002/Ptr.3675 |
0.644 |
|
| 2011 |
Caffrey AR, Woodmansee SB, Crandall N, Tibert C, Fielding C, Mikolich DJ, Vezeridis MP, LaPlante KL. Low adherence to outpatient preoperative methicillin-resistant Staphylococcus aureus decolonization therapy. Infection Control and Hospital Epidemiology. 32: 930-2. PMID 21828980 DOI: 10.1086/661787 |
0.311 |
|
| 2010 |
Socha AM, Tan NY, LaPlante KL, Sello JK. Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent. Bioorganic & Medicinal Chemistry. 18: 7193-202. PMID 20833054 DOI: 10.1016/J.Bmc.2010.08.032 |
0.358 |
|
| 2010 |
McConeghy KW, LaPlante KL. In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease. 68: 1-6. PMID 20727462 DOI: 10.1016/j.diagmicrobio.2010.04.011 |
0.36 |
|
| 2009 |
LaPlante KL, Woodmansee S. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrobial Agents and Chemotherapy. 53: 3880-6. PMID 19564363 DOI: 10.1128/AAC.00134-09 |
0.392 |
|
| 2009 |
LaPlante KL, Mermel LA. In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains. Antimicrobial Agents and Chemotherapy. 53: 3166-9. PMID 19451302 DOI: 10.1128/AAC.01642-08 |
0.373 |
|
| 2009 |
McConeghy KW, Mikolich DJ, LaPlante KL. Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy. 29: 263-80. PMID 19249946 DOI: 10.1592/phco.29.3.263 |
0.357 |
|
| 2009 |
Socha AM, Laplante KL, Russell DJ, Rowley DC. Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis. Bioorganic & Medicinal Chemistry Letters. 19: 1504-7. PMID 19185486 DOI: 10.1016/J.Bmcl.2009.01.010 |
0.648 |
|
| 2008 |
LaPlante KL, Leonard SN, Andes DR, Craig WA, Rybak MJ. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models. Antimicrobial Agents and Chemotherapy. 52: 2156-62. PMID 18411321 DOI: 10.1128/Aac.01046-07 |
0.324 |
|
| 2007 |
LaPlante KL, Rybak MJ, Amjad M, Kaatz GW. Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureus. Pharmacotherapy. 27: 3-10. PMID 17192156 DOI: 10.1592/phco.27.1.3 |
0.308 |
|
| 2006 |
Socha AM, LaPlante KL, Rowley DC. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates. Bioorganic & Medicinal Chemistry. 14: 8446-54. PMID 16979896 DOI: 10.1016/J.Bmc.2006.08.038 |
0.642 |
|
| 2006 |
LaPlante KL, Rybak MJ, Leuthner KD, Chin JN. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model. Antimicrobial Agents and Chemotherapy. 50: 1298-303. PMID 16569844 DOI: 10.1128/AAC.50.4.1298-1303.2006 |
0.396 |
|
| 2006 |
Ward KE, Mersfelder TL, LaPlante KL. Oritavancin--an investigational glycopeptide antibiotic. Expert Opinion On Investigational Drugs. 15: 417-29. PMID 16548791 DOI: 10.1517/13543784.15.4.417 |
0.401 |
|
| 2005 |
Rybak MJ, LaPlante KL. Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy. 25: 74-85. PMID 15767223 DOI: 10.1592/phco.25.1.74.55620 |
0.336 |
|
| 2004 |
LaPlante KL, Rybak MJ. Daptomycin - a novel antibiotic against Gram-positive pathogens. Expert Opinion On Pharmacotherapy. 5: 2321-31. PMID 15500379 DOI: 10.1517/14656566.5.11.2321 |
0.373 |
|
| 2004 |
LaPlante KL, Rybak MJ. Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline. Diagnostic Microbiology and Infectious Disease. 50: 125-30. PMID 15474322 DOI: 10.1016/j.diagmicrobio.2004.06.014 |
0.308 |
|
| Show low-probability matches. |